Similar Articles
Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease
Ayhan ÖZTÜRK, Hilmi UYSAL
Subacute Myleo-Optic Neuropathy- Case Report
Egemen VARDARLI, Gürbüz GÜMÜŞDİŞ, Sevgi TAVUS
P300 and P300 Topographic Mapping in Parkinson's Disease
Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU
Moclobemide Therapy in Chronic Tension Type Headache: Clinical and Neurophysiological (P300) Follow-up.
Sibel ÖZKAYNAK, Zülküf ÖNAL, Berrin AKTEKİN, Sevin BALKAN, Uğur KAHVECİOĞLU, Korkut YALTKAYA
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Intravenous Immunoglobulin Treatment in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Sevim ERDEM, Kubilay VARLI, Gülay NURLU, Okay SARIBAŞ, Ersin TAN
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
The potential of biomarkers to predict futile recanalization in stroke patients receiving endovascular treatment
Firat Karaaslan, Reşit Yilmaz, Fidel Demir, Müttalip Özbek, İbrahim Kaplan, Eşref Akil
DOI: 10.55697/tnd.2025.216
Distinguishing Alzheimer's disease from Parkinson's disease dementia using Enhanced Cued Recall test subscores
Ezgi Yetim, Ezgi Demirel, Ayse Akyay, Gul Yalcin Cakmakli, Esen Saka
DOI: 10.55697/tnd.2025.136
Investigation of mutations in early-onset Parkinson’s disease through next-generation sequencing analysis
Tuba Sözen Turk, Ahmet Acarer, Asude Durmaz, Burak Durmaz, Figen Gokcay, Zafer Colakoglu, Haluk Akın, Ozgur Cogulu, Ayca Aykut
DOI: 10.55697/tnd.2025.163